Inhibition of human lung adenocarcinoma growth using SurvivinT34A by low-dose systematic administration

Journal of Biosciences

Volumn 35, Issue 2, 2010, Pages 209-216

  Shan, Yan ^a   Wang, Chunting ^a   Yang, Li ^a   Chen, Li Juan ^a   Deng, Hong Xin ^a   Yang, Han Shuo ^a   Li, Zhimian ^a   Li, Zhiyong ^a   Pan, Li ^a   Leng, Fei ^a   Wei, Yuquan ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Apoptosis; Cationic liposome; Human lung adenocarcinomas; Survivin

Indexed keywords

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; CD31 ANTIGEN; PLASMID VECTOR; PROPIDIUM IODIDE; SURVIVIN; SURVIVIN T34A; UNCLASSIFIED DRUG;

APOPTOSIS; ASSAY; CANCER; INHIBITION; LIPID; PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FLOW CYTOMETRY; GENE DELIVERY SYSTEM; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LIPOSOMAL DELIVERY; LUNG ADENOCARCINOMA; MOUSE; NICK END LABELING; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; STAINING; TUMOR XENOGRAFT;

ADENOCARCINOMA; ANIMALS; CELL LINE, TUMOR; FEMALE; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM TRANSPLANTATION; PLASMIDS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS MUSCULUS;

EID: 78651334130     PISSN: 02505991     EISSN: 02505991     Source Type: Journal    
DOI: 10.1007/s12038-010-0025-3     Document Type: Article

References (36)

1. Altieri D C 2001 The molecular basis and potential role of survivin in cancer diagnosis and therapy; Trends. Mol. Med. 7 542-547
2. Altieri D C and Marchisio C 1999 Survivin apoptosis: an interloper between cell death and cell proliferation in cancer; Lab. Invest. 79 1327-1333
3. Blanc-Brude O P, Mesri M, Wall N R, Plescia J, Dohi T and Altieri D C 2003 Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis; Clin. Cancer Res. 9 2683-2692
4. Bo L, Yi M, Carolyn C, Fenghua Z, Sylke S, Jiahui T, Jim P, Jun. C et al. 2004 Survivin as a therapeutic target for radiation sensitization in lung cancer; Cancer Res. 64 2840-2845
5. Branko Z 2007 Report 2007 12th World Conference on Lung Cancer. Seoul, Korea.
6. Chakravarti A, Noll E, Black P M, Finkelstein D F, Finkelstein D M, Dyson N J and Loeffler J S 2002 Quantitatively determined survivin expression levels are of prognostic value in human gliomas; J. Clin. Oncol. 20 1063-1068
7. Connor D S, Grossman G, Plescia J, Li F, Zhang H, Villa A, Tognin S, Marchisio P C et al. 2000 Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin; Proc. Natl. Acad. Sci. USA 97 13103-13107
8. Connor D S, Schechner J S, Adida C, Mesri M, Rothermel A L, Li F, Nath A K, Pober J S et al. 2000 Control of apoptosis during angiogenesis by survivin expression in endothelial cells; Am. J. Pathol. 156 393-398
9. Connor D S, Wall N R, Porter A C G and Altieri D C 2002 A p34cdc2 survival checkpoint in cancer; Cancer Cell 2 43-54
10. Deveraux Q L and Reed J C 1999 IAP family proteins: suppressors of apoptosis; Genes. Dev. 13 239-252
11. Du C, Fang M, Li Y, Li L and Wang X 2000 Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition; Cell 102 33-42
12. Grossman D, Kim P J, Schechner J S and Altieri D C 2001 Inhibition of melanoma tumor growth in vivo by survivin targeting; Proc. Natl. Acad. Sci. USA 98 635-640
13. Grossman D, McNiff J M, Li F and Altieri D C 1999 Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma; J. Invest. Dermatol. 113 1076-1081
14. Harfouche R, Hassessian H M, Guo Y, Faivre V, Srikant C B, Yancopoulos G D and Hussain S N 2002 Mechanisms which mediate the antiapoptotic effects of angiopoietin-1 on endothelial cells; Microvasc. Res. 64 135-147
15. Ito I, Began G, Mohiuddin I, Saeki T, Saito Y, Branch C D, Vaporciyan A, Stephens L C et al. 2003 Increased uptake of liposome-DNA complexes by lung metastases following intravenous administration; Mol. Ther. 7 409-418
16. Jiang G, Li J, Zeng Z and Xian L 2006 Lentivirus-mediated gene therapy by suppressing survivin in BALB/c nude mice bearing oral squamous cell carcinoma; Cancer Biol. Ther. 5 435-440
17. Kanwar J R, Shen W P, Kanwar R K, Berg R W and Krissansen G W 2001 Effects of survivin antagonists on growth of established tumors and B7-1 immunogene therapy; J. Natl. Cancer Inst. 93 1541-1552
18. Kennedy S M, Driscoll L, Purcell R, Fitz-Simons N, McDermott E W, Hill A D, Higgins N J, Parkinson M et al. 2003 Prognostic importance of survivin in breast cancer; Br. J. Cancer 88 1077-1083
19. Lu B, Gonzalez A, Massion P P, Shyr Y, Shaktour B, Carbone D P and Hallahan D E 2004 Nuclear survivin as a biomarker for nonsmall-cell lung cancer; Br. J. Cancer 91 537-540 (Pubitemid 39093575)
20. Mehdi M, Nathan R, Jia L, Richard W. Kim and Dario C 2001 Cancer gene therapy using a survivin mutant adenovirus; J. Clin. Invest. 108 981-990
21. Mesri M, Morales-Ruiz M, Ackermann E J, Bennett C F, Pober J S, Sessa W C and Altieri D C 2001 Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting; Am. J. Pathol. 158 1757-1765
22. Mohamed S, Yasufuku K, Nakajima T, Hiroshima K, Chiyo M, Sekine Y, Shibuya K, Agamy G et al. 2009 Nuclear survivin in pN2 nonsmall cell lung cancer: prognostic and clinical implications; Eur. Respir. 33 127-133
23. Muzio L, Staibano S, Pannone G, Mignogna M D, Mariggio A, Salvatore G, Chieffi P, Tramontano D et al. 2001 Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma; Exp. Mol. Pathol. 70 249-254
24. Papapetropoulos A, Fulton D, Mahboubi K, Kalb R G, Connor D S, Li F, Altieri D C and Sessa W C 2000 Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway; J. Biol. Chem. 275 9102-9105
25. Peng X C, Yang L, Yang L P, Mao Y Q, Yang H S, Liu J Y, Zhang D M, Chen L J et al. 2008 Efficient inhibition of murine breast cancer growth and metastasis by gene transferred mouse survivin Thr34?Ala mutant; J. Exp. Clin. Cancer Res. 27 46-59
26. Pennati M, Colella G, Folini M, Citti L, Daidone M G and Zaffaroni N 2002 Ribozyme-mediated attenuation of survivin expression sensitizes human melanoma cells to cisplatin-induced apoptosis; J. Clin. Invest. 109 285-286
27. Pisarev V, Yu B, Salup R, Sherman S and Gabrilovich D I 2003 Fulllength dominant-negative survivin for cancer immunotherapy; Clin. Cancer Res. 9 6523-6533
28. Ramesh R, Saeki T, Templeton N S, Ji L, Stephens L C, Ito I, Wilson D R, Wu Z et al. 2001 Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vector; Mol. Ther. 22 11-16
29. Reed J C 1999 Dysregulation of apoptosis in cancer; J. Clin. Oncol. 17 2941-2953
30. Robert A, Olie A, Paula S, Bettina B, Sian H L, Doriano F, Rolf A and Stahel U 2000 A Novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy; Cancer Res. 60 2805-2809
31. Rudin C M and Thompson C B 1997 Apoptosis and disease: regulation and clinical relevance of programmed cell death; Annu. Rev. Med. 48 267-281
32. Shen C X, Liu W J, Andreas K B and Sven N R 2009 Pro-apoptosis and anti-proliferation effects of a recombinant dominantnegative survivin-t34a in human cancer cells; Anticancer Res. 29 1423-1428
33. Shi Y 2002 Mechanisms of caspase activation and inhibition during apoptosis; Mol. Cell. 9 459-470
34. Thurston G, Mclean J W, Rizen M, Baluk P, Haskell A, Murphy T J, Hanahan D and McDonald D M 1998 Cationic liposome target angiogenic endothelial cells in tumors and chronic inflammation in mice; J. Clin. Invest. 101 1401-1413
35. Tsuruma T, Hata F, Torigoe T, Furuhata T, Idenoue S, Kurotaki T, Yamamoto M, Yagihashi A et al. 2004 Phase I clinical study of antiapoptosis protein, surviving derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer; J. Transl. Med. 2 19-30
36. Verdecia M A, Huang H, Dutil E, Kaiser D A, Hunter T and Noel J P 2000 Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement; Nat. Struct. Biol. 7 602-608